Cited by 359Inflammatory mediators and NSAID effectsColorectal Cancer Screening and DetectionColorectal Cancer Treatments and Studies

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs

García Rodríguez, Luis A., Huerta-Alvarez, Consuelo·2001·Epidemiology

DOI 10.1097/00001648-200101000-00015

Open this paper in CoChat — free account

Abstract

Use of nonsteroidal antiinflammatory drugs (NSAIDs) has been associated with a reduced risk of colorectal cancer, but limited information is available on the effect of individual nonaspirin NSAIDs. In addition, the dose-response relation of aspirin in reducing the risk of colorectal cancer has not been described. We carried out a population-based cohort study with secondary case-control analysis to determine the association between the risk of colorectal cancer and use of aspirin and individual NSAIDs, including the role of dose and duration. The General Practice Research Database in the U.K. was the source population. We traced 943,903 persons 40-79 years of age and free of cancer and colorectal adenoma between January 1994 and September 1997. A total of 2,002 incident cases of colorectal cancer were ascertained. The incidence rate of colorectal cancer per 10,000 person-years was 7.3. The risk of colorectal cancer was reduced in users of nonaspirin NSAIDs and became evident after 6 months of continuous treatment. The adjusted relative risk was 0.5 (95% confidence interval = 0.4-0.7). The reduction in risk disappeared completely 1 year after stopping NSAID treatment. The risk of developing colorectal cancer was reduced in long-term users of aspirin at doses of 300 mg daily (relative risk = 0.6; 95% confidence interval = 0.4-0.9). Daily doses of 75 and 150 mg aspirin were not associated with a reduced risk of colorectal cancer. Our data support the existence of an important protective effect of nonaspirin NSAID continuous intake against colorectal cancer and point to a similar reduction in risk for aspirin at doses of at least 300 mg daily. One-year treatment with NSAIDs would prevent one case of colorectal cancer in a population of 1,000 persons 70-79 years of age.

Integrity signals

Registry

Crossref · 10.1097/00001648-200101000-00015

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Aramandla, R., Giardiello, F. M., Ferrenbach, S., & DuBois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,512
Aspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E. L., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,095
Aspirin use and risk of fatal cancer.
Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., & Heath, C. W. (1993) · PubMed · Cited by 870
Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
Giovannucci, E. L., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00001 · Cited by 784
Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study
Schreinemachers, D. M., & Everson, R. B. (1994) · Epidemiology · doi:10.1097/00001648-199403000-00003 · Cited by 738
Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study
Kune, G. A., Kune, S., & Watson, L. F. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym193 · Cited by 654
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H., Hacker, D. G., Hoover, R. N., & Fraumeni, J. F. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.307 · Cited by 580
Prophylactic aspirin and risk of peptic ulcer bleeding
Weil, J., Colin-Jones, D. G., Langman, M. J. S., Lawson, D. H., Logan, R., Murphy, M. S., Rawlins, M. D., Vessey, M. P., & Wainwright, P. (1995) · BMJ · doi:10.1136/bmj.310.6983.827 · Cited by 563

Show all 29 references

Research works printed but not linked: 4

Vainio, 1997, Cancer Epidemiol Biomarkers Prev, 6, 749
Kune, 1988, Cancer Res, 48, 4399
Reeves, 1996, Cancer Epidemiol Biomarkers Prev, 5, 955
Thun, 1993, Cancer Res, 53, 1322

Sorted by citations

Items 301–358 of 358

CLINICAL-ALIMENTARY TRACT Risk of Colorectal Cancer in Patients Prescribed Statins, Nonsteroidal Anti-Inflammatory Drugs, and Cyclooxygenase-2 Inhibitors: Nested Case-Control Study
Vinogradova, Y., Coupland, C. A. C., & Logan, R. F. (2007) · Cited by 1
The Role of Inflammation in Mediating Risk for Medical Disorders in Depressed Patients
Currier, M. B. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150501-07 · Cited by 1
Epidemiology, risk factors, and prevention
Smith, R. K., & Maron, D. J. (2016) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2016.04.014 · Cited by 1
The Interplay Between Inflammatory Signaling and Nuclear Structure and Function
Hubáčková, S., Moravcová, S., & Hodný, Z. (2016) · Springer eBooks · doi:10.1007/978-3-319-38882-3_12 · Cited by 1
From Inflammation to Cancer
Lee, J., Lee, E., Na, H., & Surh, Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805417-8.00016-0 · Cited by 1
Biological Evaluation of Two 1,4-Naphthoquinone Derivatives Against a Breast Human Adenocarcinoma Cell Line.
Creţu, F. M., Stănoiu, B. P., Pisoschi, C. G., Predescu, A. M., & Rău, G. (2017) · Europe PMC (PubMed Central) · doi:10.12865/chsj.43.04.08 · Cited by 1
Eflornithine for the Chemoprevention of Luminal Gastrointestinal Neoplasms: A Systematic Review
Godoy, A., Montalvan-Sanchez, D. M., Príncipe-Meneses, F. S., Riva-Moscoso, A., Sierra, L., Erazo, G. B., Avila, C., Rojas, M. R., Giron, R., & Guifarro, D. A. (2025) · Gastroenterology Research · doi:10.14740/gr1801 · Cited by 1
Estrategias de prevención primaria y tamización para cáncer colorrectal: ¿cuál estrategia debemos tomar?
Flórez, C. E. P., Vargas, F., & Barriga, J. C. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
The role of protein phosphatase 2A in inflammation and cancer
Enjoji, S., & Ohama, T. (2017) · Folia Pharmacologica Japonica · doi:10.1254/fpj.149.208 · Cited by 1
Macrophages in tumour development and metastasis
Eichten, A., de Visser, K. E., & Coussens, L. M. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6729-7_8 · Cited by 1
Diet and gastrointestinal cancer : one-carbon metabolism and other aspects
Larsson, S. C. (2006) · Figshare · doi:10.13140/rg.2.2.36541.67040 · Cited by 1
Characterization of the Role of CXCL10 and CXCR3 in Breast Cancer
Raitman, I. (2010) · TSpace (University of Toronto) · Cited by 1
Transposable Elements in Human Diseases: Evolutionary and Therapeutic PerspectivesPreprint
Shah, K., & Berkyurek, A. C. (2022) · Preprints.org · doi:10.20944/preprints202205.0117.v1 · Cited by 1
Perhaps not everyone knows that…
(2001) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a000238 · Cited by 1
Role of Inflammation in Metastatic Progression
Kim, S., & Karin, M. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976117.016
Carcinogênese induzida por DMBA em camundongo selecionados para a alta ou baixa produção de anticorpos.
Antonio, A. L. (2014) · doi:10.11606/d.42.2014.tde-24092014-180622
Regulatory Mechanism of Myeloid Derived Suppressor Cell Activity
Corzo, C. A. (2010) · Digital Commons - University of South Florida (University of South Florida)
Evaluation of a novel, serum-based, biomarker screening test for colorectal cancer.
Elshoni, H. (2012) · University Library - University of Saskatchewan (University of Saskatchewan)
New Insights into Genetic Variation and Cancer
Siemes, C. (2007) · EUR Research Repository (Erasmus University Rotterdam)
Cyclooxygenase-2 as a Target for Cancer Prevention and Treatment
Bertagnolli, M. M., Viner, J. L., & Hawk, E. T. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-337-0_21
Pre Clinical and Clinical Studies of the Effects of Resveratrol, a Phytochemical With Potential Chemopreventive Efficacy
Brown, V. A. (2010) · Leicester Research Archive (University of Leicester)
Signaling and regulation of cysteinyl leukotriene receptors in intestinal epithelial cells and colon cancer
Bengtsson, Å. (2009) · Lund University Publications (Lund University)
Epidemiologische Studien zur Evaluierung der Eignung von Cyclooxygenase in der Chemopravention von malignen Tumoren*
Schernhammer, E. S., & Dittrich, C. (2003) · Wiener Medizinische Wochenschrift · doi:10.1046/j.1563-258x.2003.03004.x
Chirurgische Konzepte und Strategien bei Kolonadenomen und Polyposissyndromen
Pistorius, S. R., Wehrmann, U., Teichert, E.-M., & Saeger, H. D. (2002) · Visceral Medicine · doi:10.1159/000064174
Prevención primaria y clasificación del riesgo del cáncer colorrectal
Beceiro, B. B., Andreu, M. G., Santos, J. F., & Arbeloa, Á. L. (2005) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(05)74546-1
Der Einfluss von Insulin Glargin auf frühe Stadien der Kolonkarzinogenese in der diabetischen db/db-Maus
Staffa, J. (2013) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16276
INFLAMMATORY MECHANISMS OF CHEMOKINE RECEPTOR 7 EXPRESSION IN METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
Mburu, Y. K. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Nitric oxide-donating aspirins spare the gastrointestinal (GI) system and improve the treatment of inflammation-related GI and cardiovascular pathologies
Bolla, M., Acuto, G., & Soldato, P. D. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7930-9_5
Análise da expressão diferencial dos genes envolvidos na resposta inflamatória aguda e crônica e sua influência na carcinogênese química cutânea em camundongos geneticamente selecionados para alta ou baixa reatividade inflamatória aguda.
Carneiro, P. D. S. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2009.tde-08072009-142404
The link between obesity, colorectal cancer progression and tumour angiogenesis
Volkova, E. (2011) · Otago University Research Archive (University of Otago)
Ciclooxigenasa 2 y cáncer colorrectal: implicaciones terapéuticas
Castells, A., Balaguer, F., Gonzalo, V., & Castellvı́-Bel, S. (2007) · Gastroenterología y Hepatología · doi:10.1157/13101980
Anti-diabetic treatment and cancer occurrence among patients with type II diabetes mellitus
Qiu, H. (2011) · doi:10.7282/t3930s81
INDUCTION OF GLIOMA STEM CELLS BY INTERLEUKIN-1BETA AND TRANSFORMING GROWTH FACTOR-BETA
Liu, Z. (2011) · K-State Research Exchange (Kansas State University)
Ný og gömul gigtarlyf. Áhætta og ávinningur
Summary, E. (2003)
CLINICAL-ALIMENTARY TRACT Chronic Proton Pump Inhibitor Therapy and the Risk of Colorectal Cancer
Yang, Y., Hennessy, S., PROPERT, K. J., Sedarat, A., & Lewis, J. D. (2007)
Meta-analyses of colorectal cancer risk factors Constance M. JohnsonCaimiao WeiJoe E. Ensor • Derek J. SmolenskiChristopher I. AmosBernard Levin •
Berry, D. A. (2013)
survival from colorectal cancer Effect of aspirin and NSAIDs on risk and
Din, F. V. N., & Farrington, S. M. (2010)
Benign Tumors of the Anorectum
Mohan, R. (2015) · Springer eBooks · doi:10.1007/978-81-322-2589-8_15
Influencia del consumo de antiinflamatorios no esteroideos en la incidencia de cáncer de mama: = Influence of non-streroidal antiinflammatory drugs use on breast cancer incidence
de Cárdenas, M. D. P. (2015)
Identification of a role for B7-H4 in neutrophil homeostasis and innate immunity
Augustine, M. M. (2014)
Prevention and treatment of familial adenomatous polyposis and colorectal cancer by bilberry-derived anthocyanidins.
Mudd, A. M. (2017) · doi:10.18297/etd/2801
Influence of bilberry-derived anthocyanidins on key regulators of colorectal cancer development.
Mudd, A. M. (2018) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3129
Assessing the Utility of the General Practice Research Database (GPRD) to Identify Major Congenital Heart Defects
Wurst, K. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/pvxt-0m45
Clinical Applications of Aspirin
Schrör, K. (2016) · Wiley eBooks · doi:10.1002/9783527685059.ch4
El Proyecto BIFAP: Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria
Rosa, A. S., Pérez, J. C. M., Sonego, D., Rodriguez, L. A. G., & Iglesias, F. J. D. A. (2003) · Atención Primaria · doi:10.1016/s0212-6567(03)76324-0
Chemoprevention
Hubner, R. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6694-0_11
Data from Effect of Suppressive Oligodeoxynucleotides on the Development of Inflammation-Induced Papillomas
Ikeuchi, H., Kinjo, T., & Klinman, D. M. (2023) · doi:10.1158/1940-6207.c.6544631.v1
Data from Effect of Suppressive Oligodeoxynucleotides on the Development of Inflammation-Induced Papillomas
Ikeuchi, H., Kinjo, T., & Klinman, D. M. (2023) · doi:10.1158/1940-6207.c.6544631
Supplementary Appendices from Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic
Meyskens, F. L., Curt, G. A., Brenner, D. E., Gordon, G., Herberman, R. B., Finn, O. J., Kelloff, G. J., Khleif, S. N., Sigman, C. C., & Szabo, E. M. (2023) · doi:10.1158/1940-6207.22525025
Supplementary Appendices from Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic
Meyskens, F. L., Curt, G. A., Brenner, D. E., Gordon, G., Herberman, R. B., Finn, O. J., Kelloff, G. J., Khleif, S. N., Sigman, C. C., & Szabo, E. M. (2023) · doi:10.1158/1940-6207.22525025.v1
Tumor Ecosystem-Directed Therapeutic Strategies
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_30
Carcinoma colorrectal de inicio temprano en un hospital de tercer nivel: un estudio transversal
Montiel-Jarquín, Á. J., Ramos, J. I. B., Pérez-Corro, M. Á., & López-Bernal, C. A. (2023) · Revista Médica de la Universidad Veracruzana · doi:10.25009/rmuv.2022.2.67
THE ROLE OF PAK1 IN THE CELLULAR AND MOLECULAR COMPONENTS OF PLEXIFORM NEUROFIBROMAS
McDaniel, A. S. (2008) · doi:10.7912/c2/1684
Desenvolvimento de melanoma em animais selecionados pela intensidade de resposta inflamatória aguda (Airmax/Airmin): caracterização das células Natural Killer, NKT, Treg e perfil de citocinas
Castoldi, L. (2007) · Americanae (AECID Library)
Rôle des mastocytes dans le développement des astrocytomes humains : implication du récepteur CD47
Boukhari, A. A. (2012) · theses.fr (ABES) · doi:10.70675/3c922fc3z5510z47b6zba8ezeb4143cfb7ba
Evaluation de l’effet de l’aspirine à faible dose sur le risque de cancer dans le Système National de Données de Santé
AJROUCHE, A. (2019) · doi:10.70675/0569103fzbf4az4b00z8db0zd4f6aa61f999
Le lien entre auto-immunité et immunosurveillance des cancers dans le cas des cholangites et du cholangiocarcinome
Paillet, J. (2020) · theses.fr (ABES) · doi:10.70675/0fdedffez92dfz4dc3zbe4ez9fdf1fa28a26
Vergleich der Genexpression im entzündlichen Kolonepithel und im kolorektalen Karzinom im Hinblick auf das erhöhte Tumorrisiko bei chronisch entzündlichen Darmerkrankungen
Eilers, K. (2008) · doi:10.53846/goediss-253

Authors: García Rodríguez, L. A., & Huerta-Alvarez, C.
Venue: Epidemiology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2001-01
Volume: 12
Issue: 1
Pages: 88-93
ISSN: 1044-3983 (ISSN-L)
DOI: 10.1097/00001648-200101000-00015
OpenAlex: W1971370481
Cited by: 359
References: 29
Citations by year: 2026: 1 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 4 · 2021: 5 · 2020: 11 · 2019: 6 · 2018: 11 · 2017: 10 · 2016: 16 · 2015: 15 · 2014: 11 · 2013: 14 · 2012: 19
FWCI: 16.04
Type: journal article
Language: en
Open access: closed
Locations: Epidemiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords: colorectal cancer, aspirin, nonsteroidal anti-inflammatory drugs, chemoprevention, dose-response relationship, long-term drug use, cancer incidence, colorectal adenoma
MeSH terms: Adenoma, Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Female, United Kingdom, Humans, Male, Middle Aged, Risk Factors, Colorectal Neoplasms, Cohort Studies, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks